Preface | p. ix |
About the editors | p. x |
Contributors | p. xii |
Abbreviations | p. xiv |
Introduction to Good Clinical Practice | p. 1 |
Regulatory requirements | p. 15 |
Introduction | p. 15 |
International Conference on Harmonisation requirements | p. 15 |
The United States (US) regulatory framework | p. 17 |
The European Union regulatory framework | p. 27 |
Summary | p. 37 |
Informed consent | p. 41 |
Background | p. 42 |
Regulations and guidelines | p. 44 |
Introduction to form and process | p. 44 |
Liability, understanding, therapeutic misconception | p. 51 |
Developing a 'gold standard' | p. 54 |
Leadership | p. 57 |
Additional topics | p. 57 |
Summary | p. 60 |
Investigator responsibilities | p. 63 |
Qualifications | p. 64 |
Assessment of the research | p. 65 |
Communication with the Institutional Review Board or Independent Ethics Committee | p. 67 |
Communication with sponsor | p. 68 |
Protecting safety, rights, and welfare of subjects | p. 68 |
Investigational product | p. 71 |
Safety reporting | p. 73 |
Assessment of causality | p. 73 |
Documentation and record retention | p. 74 |
Financial disclosure | p. 75 |
Inspections by health authorities | p. 75 |
Summary | p. 75 |
Sponsor responsibilities | p. 77 |
Quality | p. 77 |
Medical expertise | p. 78 |
Study design | p. 79 |
Data management | p. 80 |
Record keeping | p. 81 |
Safety reporting | p. 83 |
Investigator selection | p. 86 |
Investigational product | p. 86 |
Registration of clinical trials | p. 88 |
Reporting of clinical trial results | p. 88 |
Summary | p. 89 |
Clinical trial design | p. 91 |
Introduction | p. 91 |
What is clinical research? | p. 91 |
Historical perspective on clinical research | p. 92 |
Why is clinical research needed? | p. 92 |
The phases of drug development | p. 93 |
Where does clinical research begin? | p. 95 |
Critical concepts in clinical research | p. 95 |
Approaches to the design of clinical research studies | p. 95 |
Bias in clinical research | p. 98 |
Type I error, Type II error, and sample size | p. 100 |
Equivalency/non-inferiority versus superiority in clinical trials | p. 102 |
Clinical equipoise in controlled clinical trials | p. 104 |
Comparison of placebo versus the best-available control group in controlled clinical studies | p. 105 |
Challenges in conducting clinical research | p. 105 |
The interpretation and integration of clinical research into clinical practice | p. 106 |
Site monitoring | p. 109 |
Selection and qualifications of the monitor | p. 109 |
The evaluation visit | p. 110 |
The initiation visit | p. 112 |
The monitoring visit | p. 114 |
The close-out visit | p. 117 |
Summary | p. 119 |
Institutional Review Boards and Independent Ethics Committees | p. 121 |
Composition, procedures, and function | p. 122 |
Protection of human subjects | p. 125 |
Review of the protocol, Investigator's Brochure, and informed consent | p. 128 |
Qualifications of the investigator and investigative team | p. 138 |
Risk-benefit analysis | p. 139 |
Continuing review | p. 144 |
Final thoughts | p. 145 |
Pharmacovigilance | p. 149 |
Introduction | p. 149 |
Adverse events | p. 150 |
Reporting guidelines and timeline | p. 153 |
Signal detection | p. 159 |
Databases | p. 161 |
Conclusion | p. 163 |
Clinical trial registration and reporting | p. 167 |
Introduction and history | p. 167 |
Clinical trial registration | p. 170 |
Clinical trial results databases | p. 175 |
Legislation and regulatory requirements | p. 177 |
Clinical trial disclosure implications for future therapeutic development | p. 178 |
Summary | p. 180 |
Quality assurance | p. 183 |
Introduction | p. 183 |
Defining quality | p. 184 |
Auditing: purpose of auditing | p. 185 |
The audit plan | p. 186 |
Conduct of the audit | p. 188 |
Types of audit | p. 188 |
Summary | p. 200 |
Future implications of Good Clinical Practice | p. 203 |
Globalization of clinical research | p. 203 |
Genomics | p. 205 |
Gene transfer | p. 207 |
Stem cell research | p. 208 |
Nanotechnology | p. 210 |
Conclusion | p. 212 |
The Nuremberg Code | p. 215 |
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects | p. 217 |
The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research | p. 223 |
Glossary | p. 235 |
Index | p. 245 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.